Cargando…
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients
BACKGROUND: Systemic allergic reactions are a risk for allergen immunotherapy that utilizes intact allergen preparations. We evaluated the safety, efficacy and immune mechanisms of short‐course treatment with adjuvant‐free Lolium perenne peptides (LPP) following a 6‐week dose‐escalation protocol. ME...
Autores principales: | Mösges, R., Koch, A. F., Raskopf, E., Singh, J., Shah‐Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R., Shamji, M. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032848/ https://www.ncbi.nlm.nih.gov/pubmed/29322510 http://dx.doi.org/10.1111/all.13392 |
Ejemplares similares
-
A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy
por: Mösges, R., et al.
Publicado: (2017) -
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double‐blind, placebo‐controlled trial
por: Mösges, R., et al.
Publicado: (2018) -
Acupuncture in allergic rhinitis: A Mini-Review
por: Hauswald, Bettina, et al.
Publicado: (2014) -
Vernalization Mediated Changes in the Lolium perenne Transcriptome
por: Paina, Cristiana, et al.
Publicado: (2014) -
Karyotype reshufflings of Festuca pratensis × Lolium perenne hybrids
por: Majka, Joanna, et al.
Publicado: (2017)